Common use of Inquiries Clause in Contracts

Inquiries. For grant agreement and other administrative matters: Director of Research Administration The Leukemia & Lymphoma Society, Inc. 0 Xxxxxxxxxxxxx Xxxxx, Xxxxx 000 Xxx Xxxxx, XX 00000 Email: Xxxxxxxxxxxxxxxx@xxx.xxx For news and publications matters only: LLS Research Communications The Leukemia & Lymphoma Society, Inc. 0 Xxxxxxxxxxxxx Xxxxx, Xxxxx 000 Xxx Xxxxx, XX 00000 Email: XXXXxxxxxxxXxxxxxxxxxxxxx@xxx.xxx Each party acknowledges having read this entire Grant Agreement and with the full power and authority to execute this Agreement, agrees to perform in accordance with the terms and conditions contained herein. The Leukemia & Lymphoma Society, Inc. LLS Institutional Official Signature: Signature: Print Name: Xxx Xxxxxxxxxxx, Ph.D. Print Name: Xxxxxxxxx Xxxxxxxx Title: Chief Scientific Officer Title: Chief Administrative Officer and Chief Financial Officer Date: Date: Sponsoring Institutional Official Sponsoring Institution Technology Transfer Official Signature: Signature: Print Name: Print Name: Title: Title: Date: Date: The Grantee acknowledges that he or she has read this entire Grant Agreement and agrees with the Sponsoring Institution (but without incurring any personal liability to LLS) to comply with the obligations of the Grantee stated in this Grant Agreement. Signature: Print Name: Date: ATTACHMENT A THE GRANTEE’S APPLICATION INCLUDED BY REFERENCE ATTACHMENT B THE LEUKEMIA & LYMPHOMA SOCIETY’S PATENT AND INTELLECTUAL PROPERTY AGREEMENT The mission of The Leukemia & Lymphoma Society (LLS) is: Cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. In this regard, LLS recognizes that certain Inventions (defined below), potentially having public health, scientific, business, or commercial application or value, may be discovered or made in the course of research or development supported with funds furnished by the LLS. LLS desires that such Inventions be effectuated and brought into public use at the earliest possible time, and it recognizes that often this may be best accomplished through patenting and/or licensing of such Inventions. The Parties receiving funding from LLS agree to the following provisions regarding patent and intellectual property rights and licenses resulting from research conducted by Investigator (as defined below) and funded in whole or in part by LLS. This Patent and Intellectual Property Agreement (“IP Agreement”) forms part of the accompanying Grant Agreement between LLS and the Sponsoring Institution, executed concurrently herewith. Although intended to be consistent with the Grant Agreement, the terms of this IP Agreement supersede any conflicting terms of the Grant Agreement, to the extent any conflicting terms exist. Capitalized terms used but not defined in this IP Agreement will have the meaning given to such terms in the Agreement.

Inquiries. For grant agreement contract and other administrative matters: Director of Research Administration The Leukemia & Lymphoma Society, Inc. 0 Xxxxxxxxxxxxx XxxxxSociety 0000 Xxxxxxxxxx Xxxxxx, Xxxxx 000 Xxxxx Xxxxxx, Xxx Xxxxx, XX Xxxx 00000 Email: Xxxxxxxxxxxxxxxx@xxx.xxx For news and publications matters only: LLS Research Communications The Leukemia & Lymphoma Society, Inc. 0 Xxxxxxxxxxxxx XxxxxSociety 0000 Xxxxxxxxxx Xxxxxx, Xxxxx 000 Xxx XxxxxXxxxx Xxxxxx, XX 00000 Email: XXXXxxxxxxxXxxxxxxxxxxxxx@xxx.xxx Each party acknowledges having read this entire Grant Agreement and with the full power and authority to execute this Agreement, agrees to perform in accordance with the terms and conditions contained herein. Signatures Grantee The Leukemia & Lymphoma Society, Inc. LLS Institutional Official Inc Signature: Signature: Print Name: Print Name: Xxx Xxxxxxxxxxx, Ph.D. Print NameTitle: Xxxxxxxxx Xxxxxxxx Title: Chief Scientific Officer Title: Chief Administrative Officer and Chief Financial Officer Date: Date: Sponsoring Institutional Official Sponsoring Institution Technology Transfer LLS Institutional Official Signature: Signature: Print Name: Print Name: Xxxxxxxxx Xxxxxxxx Chief Administrative Officer and Chief Financial Officer Title: Title: Date: Date: The Grantee acknowledges that he or she has read this entire Grant Agreement and agrees with the Sponsoring Institution (but without incurring any personal liability to LLS) to comply with the obligations of the Grantee stated in this Grant Agreement. Technology Transfer Official Signature: Print Name: Title: Date: ATTACHMENT A A‌ THE GRANTEE’S APPLICATION INCLUDED BY REFERENCE ATTACHMENT B THE LEUKEMIA & LYMPHOMA SOCIETY’S PATENT AND INTELLECTUAL PROPERTY AGREEMENT The mission of The Leukemia & Lymphoma Society Society’s (“LLS”) is: Cure primary purpose in funding scientifically meritorious research is to advance its mission to cure leukemia, lymphoma, Hodgkin's ’s disease and myeloma, and to improve the quality of life of patients and their families. In this regard, LLS recognizes that certain Inventions (defined below), potentially having public health, scientific, business, or commercial application or value, may be discovered or made in the course of research or development supported with funds furnished by the LLS. LLS desires that such Inventions be effectuated and brought into public use at the earliest possible time, and it recognizes that often this may be best accomplished through patenting and/or licensing of such Inventions. The Parties receiving funding Grant funds from LLS agree to the following provisions regarding patent and intellectual property rights and licenses resulting from research conducted by Investigator (as defined below) Grantee and funded in whole or in part by LLS. This Patent and Intellectual Property Agreement (“IP Agreement”) forms part of the accompanying Grant Agreement between LLS on the one hand, and the Grantee and Sponsoring InstitutionInstitution on the other hand, executed concurrently herewith. Although intended to be consistent with the Grant Agreement, the terms of this IP Agreement supersede any conflicting terms of the Grant Agreement, to the extent any conflicting terms exist. Capitalized terms used but not defined in this IP Agreement will have the meaning given to such terms in the Agreement.

Inquiries. For grant agreement and other administrative matters: Director of Research Administration The Leukemia & Lymphoma Society, Inc. 0 Xxxxxxxxxxxxx Xxxxx, Xxxxx 000 Xxx Xxxxx, XX 00000 Email: Xxxxxxxxxxxxxxxx@xxx.xxx For news and publications matters only: LLS Research Communications The Leukemia & Lymphoma Society, Inc. 0 Xxxxxxxxxxxxx Xxxxx, Xxxxx 000 Xxx Xxxxx, XX 00000 Email: XXXXxxxxxxxXxxxxxxxxxxxxx@xxx.xxx Each party acknowledges having read this entire Grant Agreement and with the full power and authority to execute this Agreement, agrees to perform in accordance with the terms and conditions contained herein. The Leukemia & Lymphoma Society, Inc. LLS Institutional Official The Leukemia & Lymphoma Society, Inc. Signature: Signature: Print Name: Xxx Xxxxxxxxxxx, Ph.D. Print Name: Xxxxxxxxx Xxxxxxxx Title: Chief Scientific Officer Title: Chief Administrative Officer and Chief Financial Officer Date: Date: Sponsoring Institutional Official Sponsoring Institution Technology Transfer Official Signature: Signature: Print Name: Print Name: Title: Title: Date: Date: The Grantee acknowledges that he or she has read this entire Grant Agreement and agrees with the Sponsoring Institution (but without incurring any personal liability to LLS) to comply with the obligations of the Grantee stated in this Grant Agreement. Signature: Print Name: Date: ATTACHMENT A THE GRANTEE’S APPLICATION INCLUDED BY REFERENCE ATTACHMENT B THE LEUKEMIA & LYMPHOMA SOCIETY’S PATENT AND INTELLECTUAL PROPERTY AGREEMENT The mission of The Leukemia & Lymphoma Society (LLS) is: Cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. In this regard, LLS recognizes that certain Inventions (defined below), potentially having public health, scientific, business, or commercial application or value, may be discovered or made in the course of research or development supported with funds furnished by the LLS. LLS desires that such Inventions be effectuated and brought into public use at the earliest possible time, and it recognizes that often this may be best accomplished through patenting and/or licensing of such Inventions. The Parties receiving funding Grant funds from LLS agree to the following provisions regarding patent and intellectual property rights and licenses resulting from research conducted by Investigator (as defined below) Grantee and funded in whole or in part by LLS. This Patent and Intellectual Property Agreement (“IP Agreement”) forms part of the accompanying Grant Agreement between LLS and the Sponsoring Institution, executed concurrently herewith. Although intended to be consistent with the Grant Agreement, the terms of this IP Agreement supersede any conflicting terms of the Grant Agreement, to the extent any conflicting terms exist. Capitalized terms used but not defined in this IP Agreement will have the meaning given to such terms in the Agreement.

Inquiries. For grant agreement and other administrative matters: Director of Research Administration The Leukemia & Lymphoma Society, Inc. 0 Xxxxxxxxxxxxx Xxxxx, Xxxxx Xxxxx 000 Xxx Xxxxx, XX 00000 Email: Xxxxxxxxxxxxxxxx@xxx.xxx For news and publications matters only: LLS Research Communications The Leukemia & Lymphoma Society, Inc. 0 Xxxxxxxxxxxxx Xxxxx, Xxxxx Xxxxx 000 Xxx Xxxxx, XX 00000 Email: XXXXxxxxxxxXxxxxxxxxxxxxx@xxx.xxx SIGNATURE PAGE FOLLOWS Each party acknowledges having read this entire Grant Agreement and with the full power and authority to execute this Agreement, agrees to perform in accordance with the terms and conditions contained herein. The Leukemia & Lymphoma Society, Inc. LLS Institutional Official The Leukemia & Lymphoma Society, Inc. Signature: Signature: Print Name: Xxx Xxxxxxxxxxx, Ph.D. Print Name: Xxxxxxxxx Xxxxxxxx Title: Chief Scientific Officer Title: Chief Administrative Officer and Chief Financial Officer Date: Date: Sponsoring Institutional Official Sponsoring Institution Technology Transfer Official Signature: Signature: Print Name: Print Name: Title: Title: Date: Date: The Grantee acknowledges that he or she has read this entire Grant Agreement and agrees with the Sponsoring Institution (but without incurring any personal liability to LLS) to comply with the obligations of the Grantee stated in this Grant Agreement. Signature: Print Name: Date: ATTACHMENT A THE GRANTEE’S APPLICATION INCLUDED BY REFERENCE ATTACHMENT B THE LEUKEMIA & LYMPHOMA SOCIETY’S PATENT AND INTELLECTUAL PROPERTY AGREEMENT SPECIFIC TO AWARDEES OF MEDICINAL CHEMISTRY GRANTS THROUGH THE REQUEST FOR PROPOSAL The mission of The Leukemia & Lymphoma Society (“LLS”) is: Cure is to cure leukemia, lymphoma, Hodgkin's ’s disease and myeloma, and to improve the quality of life of patients and their families. In this regard, LLS recognizes that certain Inventions (defined below), potentially having public health, scientific, business, or commercial application or value, may be discovered or made in the course of research or development supported with funds furnished by the LLS. LLS desires that such Inventions be effectuated and brought into public use at the earliest possible time, and it recognizes that often this may be best accomplished through patenting and/or licensing of such Inventions. The Parties parties receiving funding from LLS agree through LLS's Screen to Lead Program agrees to the following provisions regarding patent and intellectual property rights and licenses resulting from research conducted by Investigator (as defined below) and ), whether funded in whole or in part by LLS. This Patent and Intellectual Property Agreement (“IP Agreement”) forms part of the accompanying Grant Agreement between LLS and the Sponsoring Institution, executed concurrently herewith. Although intended to be consistent with the Grant Agreement, the terms of this IP Agreement supersede any conflicting terms of the Grant Agreement, to the extent any conflicting terms exist. Capitalized terms used but not defined in this IP Agreement will have the meaning given to such terms in the Agreement.

Inquiries. For grant agreement If you have questions concerning any of the information requested, you should ask your attorney, accountant or other financial advisor. Inquiries regarding subscription procedures should be directed to Wxxxxxx Xxxxxxxxx of Dxxxxxx LLP (wxxxxxx.xxxxxxxxx@xxxxxxx.xxx; (000) 000-0000). You may also contact Bxxxx X. Xxxxxx (BXxxxxx@xxxxxxxxxx.xxx; (000) 000-0000) or the Fund’s investor relations department (SXXxxxxxXX@xxxxxxxxxx.xxx) if you have questions about the Fund. FOR ALL SUBSCRIBERS __________ [Document #] (for Stone Point use only) Subscription Agreement ________________________________ Name of Subscriber $_________________ Amount of Capital Commitment Stone Point Credit Income Fund 20 Xxxxxxxxx Xxxx Greenwich, CT 06830 Ladies and other administrative mattersGentlemen: Director The undersigned subscriber (the “Subscriber”) understands that Stone Point Credit Income Fund, a Delaware statutory trust (the “Fund”), is an externally managed, non-diversified closed-end management investment company that has elected to be treated as a business development company (a “BDC”) under the Investment Company Act of Research Administration The Leukemia & Lymphoma Society1940, Inc. 0 Xxxxxxxxxxxxx Xxxxxas amended (the “Investment Company Act”), Xxxxx 000 Xxx Xxxxxas described in the Private Placement Memorandum of the Fund (as such document may be amended, XX 00000 Email: Xxxxxxxxxxxxxxxx@xxx.xxx For news amended and publications matters only: LLS Research Communications The Leukemia & Lymphoma Societyrestated or supplemented from time to time and together with any appendices and supplements thereto, Inc. 0 Xxxxxxxxxxxxx Xxxxx, Xxxxx 000 Xxx Xxxxx, XX 00000 Email: XXXXxxxxxxxXxxxxxxxxxxxxx@xxx.xxx Each party acknowledges having read this entire Grant Agreement and with the full power and authority “Offering Document”). Subject to execute this Agreement, agrees to perform in accordance with the terms and conditions hereof, and in reliance upon the representations and warranties contained herein. The Leukemia & Lymphoma Societyin this subscription agreement (this “Subscription Agreement”), Inc. LLS Institutional Official Signature: Signature: Print Name: Xxx Xxxxxxxxxxx, Ph.D. Print Name: Xxxxxxxxx Xxxxxxxx Title: Chief Scientific Officer Title: Chief Administrative Officer and Chief Financial Officer Date: Date: Sponsoring Institutional Official Sponsoring Institution Technology Transfer Official Signature: Signature: Print Name: Print Name: Title: Title: Date: Date: The Grantee acknowledges that he or she has read this entire Grant Agreement the Subscriber irrevocably subscribes for and agrees to purchase shares of common shares of beneficial interest, par value $0.001 per share, of the Fund (“Shares”), on the terms and conditions described herein, in the Offering Document, in the Fund’s Amended and Restated Declaration of Trust (the “Declaration of Trust”), and in the Fund’s Bylaws (the “Bylaws” and together with the Sponsoring Institution (but without incurring any personal liability to LLS) to comply with the obligations Declaration of the Grantee stated in this Grant Agreement. Signature: Print Name: Date: ATTACHMENT A THE GRANTEE’S APPLICATION INCLUDED BY REFERENCE ATTACHMENT B THE LEUKEMIA & LYMPHOMA SOCIETY’S PATENT AND INTELLECTUAL PROPERTY AGREEMENT The mission of The Leukemia & Lymphoma Society (LLS) is: Cure leukemiaTrust, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. In this regard, LLS recognizes that certain Inventions (defined below), potentially having public health, scientific, business, or commercial application or value, as such documents may be discovered amended, amended and restated or made in the course of research or development supported with funds furnished by the LLS. LLS desires that such Inventions be effectuated and brought into public use at the earliest possible supplemented from time to time, and it recognizes that often this may be best accomplished through patenting and/or licensing of such Inventions. The Parties receiving funding from LLS agree to the following provisions regarding patent and intellectual property rights and licenses resulting from research conducted by Investigator (as defined below) and funded in whole or in part by LLS. This Patent and Intellectual Property Agreement (“IP AgreementGoverning Documents”) forms part of the accompanying Grant Agreement between LLS and the Sponsoring Institution, executed concurrently herewith. Although intended to be consistent with the Grant Agreement, the terms of this IP Agreement supersede any conflicting terms of the Grant Agreement, to the extent any conflicting terms exist. Capitalized terms used but not defined in this IP Agreement will have the meaning given to such terms in the Agreement).

Inquiries. For grant agreement and other administrative matters: Director of Research Administration The Leukemia & Lymphoma Society, Inc. 0 Xxxxxxxxxxxxx Xxxxx, Xxxxx 000 Xxx Xxxxx, XX 00000 Email: Xxxxxxxxxxxxxxxx@xxx.xxx For news and publications matters only: LLS Research Communications The Leukemia & Lymphoma Society, Inc. 0 Xxxxxxxxxxxxx Xxxxx, Xxxxx 000 Xxx Xxxxx, XX 00000 Email: XXXXxxxxxxxXxxxxxxxxxxxxx@xxx.xxx Each party acknowledges having read this entire Grant Agreement and with the full power and authority to execute this Agreement, agrees to perform in accordance with the terms and conditions contained herein. The Leukemia & Lymphoma Society, Inc. LLS Institutional Official The Leukemia & Lymphoma Society, Inc. Signature: Signature: Print Name: Xxx Xxxxxxxxxxx, Ph.D. Print Name: Xxxxxxxxx Xxxxxxxx Title: Chief Scientific Officer Title: Chief Administrative Officer and Chief Financial Officer Date: Date: Sponsoring Institutional Official Sponsoring Institution Technology Transfer Official Signature: Signature: Print Name: Print Name: Title: Title: Date: Date: The Grantee acknowledges that he or she has read this entire Grant Agreement and agrees with the Sponsoring Institution (but without incurring any personal liability to LLS) to comply with the obligations of the Grantee stated in this Grant Agreement. Signature: Print Name: Date: ATTACHMENT Attachment A THE GRANTEE’S APPLICATION INCLUDED BY REFERENCE ATTACHMENT The Grantee’s Application Included by reference Attachment B THE LEUKEMIA The Leukemia & LYMPHOMA SOCIETY’S PATENT AND INTELLECTUAL PROPERTY AGREEMENT Lymphoma Society’s Patent and Intellectual Property Agreement The mission of The Leukemia & Lymphoma Society (LLS) is: Cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. In this regard, LLS recognizes that certain Inventions (defined below), potentially having public health, scientific, business, or commercial application or value, may be discovered or made in the course of research or development supported with funds furnished by the LLS. LLS desires that such Inventions be effectuated and brought into public use at the earliest possible time, and it recognizes that often this may be best accomplished through patenting and/or licensing of such Inventions. The Parties receiving funding Grant funds from LLS agree to the following provisions regarding patent and intellectual property rights and licenses resulting from research conducted by Investigator (as defined below) Grantee and funded in whole or in part by LLS. This Patent and Intellectual Property Agreement (“IP Agreement”) forms part of the accompanying Grant Agreement between LLS and the Sponsoring Institution, executed concurrently herewith. Although intended to be consistent with the Grant Agreement, the terms of this IP Agreement supersede any conflicting terms of the Grant Agreement, to the extent any conflicting terms exist. Capitalized terms used but not defined in this IP Agreement will have the meaning given to such terms in the Agreement.

Inquiries. For grant agreement and other administrative matters: Director of Research Administration The Leukemia & Lymphoma Society, Inc. 0 Xxxxxxxxxxxxx Xxxxx, Xxxxx 000 Xxx Xxxxx, XX 00000 Email: Xxxxxxxxxxxxxxxx@xxx.xxx For news and publications matters only: LLS Research Communications The Leukemia & Lymphoma Society, Inc. 0 Xxxxxxxxxxxxx Xxxxx, Xxxxx 000 Xxx Xxxxx, XX 00000 Email: XXXXxxxxxxxXxxxxxxxxxxxxx@xxx.xxx Each party acknowledges having read this entire Grant Agreement and with the full power and authority to execute this Agreement, agrees to perform in accordance with the terms and conditions contained herein. The Leukemia & Lymphoma Society, Inc. LLS Institutional Official The Leukemia & Lymphoma Society, Inc. Signature: Signature: Print Name: Xxx Xxxxxxxxxxx, Ph.D. Print Name: Xxxxxxxxx Xxxxxxxx Title: Chief Scientific Officer Title: Chief Administrative Officer and Chief Financial Officer Date: Date: Sponsoring Institutional Official Sponsoring Institution Technology Transfer Official Signature: Signature: Print Name: Print Name: Title: Title: Date: Date: The Grantee acknowledges that he or she has read this entire Grant Agreement and agrees with the Sponsoring Institution (but without incurring any personal liability to LLS) to comply with the obligations of the Grantee stated in this Grant Agreement. Signature: Print Name: Date: ATTACHMENT Attachment A THE GRANTEE’S APPLICATION INCLUDED BY REFERENCE ATTACHMENT The Grantee’s Application Included by reference Attachment B THE LEUKEMIA The Leukemia & LYMPHOMA SOCIETY’S PATENT AND INTELLECTUAL PROPERTY AGREEMENT Lymphoma Society’s Patent and Intellectual Property Agreement The mission of The Leukemia & Lymphoma Society (LLS) is: Cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. In this regard, LLS recognizes that certain Inventions (defined below), potentially having public health, scientific, business, or commercial application or value, may be discovered or made in the course of research or development supported with funds furnished by the LLS. LLS desires that such Inventions be effectuated and brought into public use at the earliest possible time, and it recognizes that often this may be best accomplished through patenting and/or licensing of such Inventions. The Parties receiving funding Grant funds from LLS agree to the following provisions regarding patent and intellectual property rights and licenses resulting from research conducted by Investigator (as defined below) Xxxxxxx and funded in whole or in part by LLS. This Patent and Intellectual Property Agreement (“IP Agreement”) forms part of the accompanying Grant Agreement between LLS and the Sponsoring Institution, executed concurrently herewith. Although intended to be consistent with the Grant Agreement, the terms of this IP Agreement supersede any conflicting terms of the Grant Agreement, to the extent any conflicting terms exist. Capitalized terms used but not defined in this IP Agreement will have the meaning given to such terms in the Agreement.

Inquiries. For grant agreement and other administrative matters: Director of Research Administration The Leukemia & Lymphoma Society, Inc. 0 Xxxxxxxxxxxxx Xxxxx, Xxxxx 000 Xxx Xxxxx, XX 00000 Email: Xxxxxxxxxxxxxxxx@xxx.xxx For news and publications matters only: LLS Research Communications The Leukemia & Lymphoma Society, Inc. 0 Xxxxxxxxxxxxx Xxxxx, Xxxxx 000 Xxx Xxxxx, XX 00000 Email: XXXXxxxxxxxXxxxxxxxxxxxxx@xxx.xxx Each party acknowledges having read this entire Grant Agreement and with the full power and authority to execute this Agreement, agrees to perform in accordance with the terms and conditions contained herein. The Leukemia & Lymphoma Society, Inc. LLS Institutional Official Signature: Signature: Print Name: Xxx Xxxxxxxxxxx, Ph.D. Print Name: Xxxxxxxxx Xxxxxxxx Title: Chief Scientific Officer Title: Chief Administrative Officer and Chief Financial Officer Date: Date: Sponsoring Institutional Official Sponsoring Institution Technology Transfer Official Signature: Signature: Print Name: Print Name: Title: Title: Date: Date: The Grantee acknowledges that he or she has read this entire Grant Agreement and agrees with the Sponsoring Institution (but without incurring any personal liability to LLS) to comply with the obligations of the Grantee stated in this Grant Agreement. Signature: Print Name: Date: ATTACHMENT Attachment A THE GRANTEE’S APPLICATION INCLUDED BY REFERENCE ATTACHMENT The Grantee’s Application Included by reference Attachment B THE LEUKEMIA The Leukemia & LYMPHOMA SOCIETY’S PATENT AND INTELLECTUAL PROPERTY AGREEMENT Lymphoma Society’s Patent and Intellectual Property Agreement The mission of The Leukemia & Lymphoma Society (LLS) is: Cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. In this regard, LLS recognizes that certain Inventions (defined below), potentially having public health, scientific, business, or commercial application or value, may be discovered or made in the course of research or development supported with funds furnished by the LLS. LLS desires that such Inventions be effectuated and brought into public use at the earliest possible time, and it recognizes that often this may be best accomplished through patenting and/or licensing of such Inventions. The Parties receiving funding from LLS agree to the following provisions regarding patent and intellectual property rights and licenses resulting from research conducted by Investigator (as defined below) and funded in whole or in part by LLS. This Patent and Intellectual Property Agreement (“IP Agreement”) forms part of the accompanying Grant Agreement between LLS and the Sponsoring Institution, executed concurrently herewith. Although intended to be consistent with the Grant Agreement, the terms of this IP Agreement supersede any conflicting terms of the Grant Agreement, to the extent any conflicting terms exist. Capitalized terms used but not defined in this IP Agreement will have the meaning given to such terms in the Agreement.

Inquiries. For grant agreement Agreement and other administrative matters: Director of Research Administration The Leukemia & Lymphoma Society, Inc. 0 Xxxxxxxxxxxxx Xxxxx, Xxxxx 000 Xxx Xxxxx, XX 00000 Email: Xxxxxxxxxxxxxxxx@xxx.xxx For news and publications matters only: LLS Research Communications The Leukemia & Lymphoma Society, Inc. 0 Xxxxxxxxxxxxx Xxxxx, Xxxxx 000 Xxx Xxxxx, XX 00000 Email: XXXXxxxxxxxXxxxxxxxxxxxxx@xxx.xxx Each party acknowledges having read this entire Grant Agreement and with the full power and authority to execute this Agreement, agrees to perform in accordance with the terms and conditions contained herein. The Leukemia & Lymphoma Society, Inc. LLS Institutional Official Signature: Signature: Print Name: Xxx Xxxxxxxxxxx, Ph.D. Print Name: Xxxxxxxxx Xxxxxxxx Title: Chief Scientific Officer Title: Chief Administrative Officer and Chief Financial Officer Date: Date: Sponsoring Institutional Official Sponsoring Institution Technology Transfer Official Signature: Signature: Print Name: Print Name: Title: Title: Date: Date: The Grantee acknowledges that he or she has read this entire Grant Agreement and agrees with the Sponsoring Institution (but without incurring any personal liability to LLS) to comply with the obligations of the Grantee stated in this Grant Agreement. Signature: Print Name: Date: ATTACHMENT A THE GRANTEE’S APPLICATION INCLUDED BY REFERENCE ATTACHMENT B THE LEUKEMIA & LYMPHOMA SOCIETY’S PATENT AND INTELLECTUAL PROPERTY AGREEMENT The mission of The Leukemia & Lymphoma Society (LLS) is: Cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. In this regard, LLS recognizes that certain Inventions (defined below), potentially having public health, scientific, business, or commercial application or value, may be discovered or made in the course of research or development supported with funds furnished by the LLS. LLS desires that such Inventions be effectuated and brought into public use at the earliest possible time, and it recognizes that often this may be best accomplished through patenting and/or licensing of such Inventions. The Parties receiving funding from LLS agree to the following provisions regarding patent and intellectual property rights and licenses resulting from research conducted by Investigator (as defined below) and funded in whole or in part by LLS. This Patent and Intellectual Property Agreement (“IP Agreement”) forms part of the accompanying Grant Agreement – New Idea Award between LLS and the Sponsoring Institution, executed concurrently herewithherewith (“Grant Agreement”). Although intended to be consistent with the Grant Agreement, the terms of this IP Agreement supersede any conflicting terms of the Grant Agreement, to the extent any conflicting terms exist. Capitalized terms used but not defined in this IP Agreement will have the meaning given to such terms in the Grant Agreement.

Inquiries. For grant agreement contract and other administrative matters: Director of Research Administration The Leukemia & Lymphoma Society, Inc. 0 Xxxxxxxxxxxxx XxxxxSociety 0000 Xxxxxxxxxx Xxxxxx, Xxxxx 000 Xxxxx Xxxxxx, Xxx Xxxxx, XX Xxxx 00000 Email: Xxxxxxxxxxxxxxxx@xxx.xxx For news and publications matters only: LLS Research Communications The Leukemia & Lymphoma Society, Inc. 0 Xxxxxxxxxxxxx XxxxxSociety 0000 Xxxxxxxxxx Xxxxxx, Xxxxx 000 Xxx XxxxxXxxxx Xxxxxx, XX 00000 Email: XXXXxxxxxxxXxxxxxxxxxxxxx@xxx.xxx Each party acknowledges having read this entire Grant Agreement and with the full power and authority to execute this Agreement, agrees to perform in accordance with the terms and conditions contained herein. Signatures Grantee The Leukemia & Lymphoma Society, Inc. LLS Institutional Official Inc Signature: Signature: Print Name: Print Name: Xxx Xxxxxxxxxxx, Ph.D. Print NameTitle: Xxxxxxxxx Xxxxxxxx Title: Chief Scientific Officer Title: Chief Administrative Officer and Chief Financial Officer Date: Date: Sponsoring Institutional Official Sponsoring Institution Technology Transfer LLS Institutional Official Signature: Signature: Print Name: Print Name: Xxxxxxxxx Xxxxxxxx Chief Administrative Officer and Chief Financial Officer Title: Title: Date: Date: The Grantee acknowledges that he or she has read this entire Grant Agreement and agrees with the Sponsoring Institution (but without incurring any personal liability to LLS) to comply with the obligations of the Grantee stated in this Grant Agreement. Technology Transfer Official Signature: Print Name: Title: Date: ATTACHMENT A A‌ THE GRANTEE’S APPLICATION INCLUDED BY REFERENCE Included by reference ATTACHMENT B THE LEUKEMIA & LYMPHOMA SOCIETY’S PATENT AND INTELLECTUAL PROPERTY AGREEMENT The mission of The Leukemia & Lymphoma Society Society’s Patent and Intellectual Property Agreement The Leukemia & Lymphoma Society’s (“LLS”) is: Cure primary purpose in funding scientifically meritorious research is to advance its mission to cure leukemia, lymphoma, Hodgkin's ’s disease and myeloma, and to improve the quality of life of patients and their families. In this regard, LLS recognizes that certain Inventions (defined below), potentially having public health, scientific, business, or commercial application or value, may be discovered or made in the course of research or development supported with funds furnished by the LLS. LLS desires that such Inventions be effectuated and brought into public use at the earliest possible time, and it recognizes that often this may be best accomplished through patenting and/or licensing of such Inventions. The Parties receiving funding Grant funds from LLS agree to the following provisions regarding patent and intellectual property rights and licenses resulting from research conducted by Investigator (as defined below) Grantee and funded in whole or in part by LLS. This Patent and Intellectual Property Agreement (“IP Agreement”) forms part of the accompanying Grant Agreement between LLS on the one hand, and the Grantee and Sponsoring InstitutionInstitution on the other hand, executed concurrently herewith. Although intended to be consistent with the Grant Agreement, the terms of this IP Agreement supersede any conflicting terms of the Grant Agreement, to the extent any conflicting terms exist. Capitalized terms used but not defined in this IP Agreement will have the meaning given to such terms in the Agreement.

Inquiries. For grant agreement and other administrative matters: Director of Research Administration The Leukemia & Lymphoma Society, Inc. 0 Xxxxxxxxxxxxx Xxxxx, Xxxxx 000 Xxx Xxxxx, XX 00000 Email: Xxxxxxxxxxxxxxxx@xxx.xxx For news and publications matters only: LLS Research Communications The Leukemia & Lymphoma Society, Inc. 0 Xxxxxxxxxxxxx Xxxxx, Xxxxx 000 Xxx Xxxxx, XX 00000 Email: XXXXxxxxxxxXxxxxxxxxxxxxx@xxx.xxx Each party acknowledges having read this entire Grant Agreement and with the full power and authority to execute this Agreement, agrees to perform in accordance with the terms and conditions contained herein. The Leukemia & Lymphoma Society, Inc. LLS Institutional Official Signature: Signature: Print Name: Xxx Xxxxxxxxxxx, Ph.D. Print Name: Xxxxxxxxx Xxxxxxxx Title: Chief Scientific Officer Title: Chief Administrative Officer and Chief Financial Officer Date: Date: Sponsoring Institutional Official Sponsoring Institution Technology Transfer Official Signature: Signature: Print Name: Print Name: Title: Title: Date: Date: The Grantee acknowledges that he or she has read this entire Grant Agreement and agrees with the Sponsoring Institution (but without incurring any personal liability to LLS) to comply with the obligations of the Grantee stated in this Grant Agreement. Signature: Print Name: Date: ATTACHMENT A THE GRANTEE’S APPLICATION INCLUDED BY REFERENCE ATTACHMENT B THE LEUKEMIA & LYMPHOMA SOCIETY’S PATENT AND INTELLECTUAL PROPERTY AGREEMENT The mission of The Leukemia & Lymphoma Society (LLS) is: Cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. In this regard, LLS recognizes that certain Inventions (defined below), potentially having public health, scientific, business, or commercial application or value, may be discovered or made in the course of research or development supported with funds furnished by the LLS. LLS desires that such Inventions be effectuated and brought into public use at the earliest possible time, and it recognizes that often this may be best accomplished through patenting and/or licensing of such Inventions. The Parties receiving funding Grant funds from LLS agree to the following provisions regarding patent and intellectual property rights and licenses resulting from research conducted by Investigator (as defined below) Grantee and funded in whole or in part by LLS. This Patent and Intellectual Property Agreement (“IP Agreement”) forms part of the accompanying Grant Agreement between LLS and the Sponsoring Institution, executed concurrently herewith. Although intended to be consistent with the Grant Agreement, the terms of this IP Agreement supersede any conflicting terms of the Grant Agreement, to the extent any conflicting terms exist. Capitalized terms used but not defined in this IP Agreement will have the meaning given to such terms in the Agreement.